The non-canonical Wnt ligand Wnt5a, secreted by osteoblasts in the endosteal niche, induces and maintains prostate cancer cell dormancy via the activation of non-canonical Wnt signaling, resulting in the suppression of the canonical Wnt pathway [115]. Here, WNT5A is linked to prostate carcinoma.